Cargando…
Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes
BACKGROUND: The number of patients with non-HIV Pneumocystis pneumonia (PCP) is increasing with widespread immunosuppressive treatment. We investigated the clinical characteristics of non-HIV PCP and its association with microbiological genotypes. METHODS: Between January 2005 and March 2010, all pa...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073915/ https://www.ncbi.nlm.nih.gov/pubmed/21439061 http://dx.doi.org/10.1186/1471-2334-11-76 |
_version_ | 1782201660442935296 |
---|---|
author | Matsumura, Yasufumi Shindo, Yuichiro Iinuma, Yoshitsugu Yamamoto, Masaki Shirano, Michinori Matsushima, Aki Nagao, Miki Ito, Yutaka Takakura, Shunji Hasegawa, Yoshinori Ichiyama, Satoshi |
author_facet | Matsumura, Yasufumi Shindo, Yuichiro Iinuma, Yoshitsugu Yamamoto, Masaki Shirano, Michinori Matsushima, Aki Nagao, Miki Ito, Yutaka Takakura, Shunji Hasegawa, Yoshinori Ichiyama, Satoshi |
author_sort | Matsumura, Yasufumi |
collection | PubMed |
description | BACKGROUND: The number of patients with non-HIV Pneumocystis pneumonia (PCP) is increasing with widespread immunosuppressive treatment. We investigated the clinical characteristics of non-HIV PCP and its association with microbiological genotypes. METHODS: Between January 2005 and March 2010, all patients in 2 university hospitals who had been diagnosed with PCP by PCR were enrolled in this study. Retrospective chart review of patients, microbiological genotypes, and association with 30-day mortality were examined. RESULTS: Of the 82 adult patients investigated, 50 patients (61%) had inflammatory diseases, 17 (21%) had solid malignancies, 12 (15%) had hematological malignancies, and 6 (7%) had received transplantations. All patients received immunosuppressive agents or antitumor chemotherapeutic drugs. Plasma (1→3) β-D-glucan levels were elevated in 80% of patients, and were significantly reduced after treatment in both survivors and non-survivors. However, β-D-glucan increased in 18% of survivors and was normal in only 33% after treatment. Concomitant invasive pulmonary aspergillosis was detected in 5 patients. Fifty-six respiratory samples were stored for genotyping. A dihydropteroate synthase mutation associated with trimethoprim-sulfamethoxazole resistance was found in only 1 of the 53 patients. The most prevalent genotype of mitochondrial large-subunit rRNA was genotype 1, followed by genotype 4. The most prevalent genotype of internal transcribed spacers of the nuclear rRNA operon was Eb, followed by Eg and Bi. Thirty-day mortality was 24%, in which logistic regression analysis revealed association with serum albumin and mechanical ventilation, but no association with genotypes. CONCLUSIONS: In non-HIV PCP, poorer general and respiratory conditions at diagnosis were independent predictors of mortality. β-D-glucan may not be useful for monitoring the response to treatment, and genotypes were not associated with mortality. |
format | Text |
id | pubmed-3073915 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30739152011-04-12 Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes Matsumura, Yasufumi Shindo, Yuichiro Iinuma, Yoshitsugu Yamamoto, Masaki Shirano, Michinori Matsushima, Aki Nagao, Miki Ito, Yutaka Takakura, Shunji Hasegawa, Yoshinori Ichiyama, Satoshi BMC Infect Dis Research Article BACKGROUND: The number of patients with non-HIV Pneumocystis pneumonia (PCP) is increasing with widespread immunosuppressive treatment. We investigated the clinical characteristics of non-HIV PCP and its association with microbiological genotypes. METHODS: Between January 2005 and March 2010, all patients in 2 university hospitals who had been diagnosed with PCP by PCR were enrolled in this study. Retrospective chart review of patients, microbiological genotypes, and association with 30-day mortality were examined. RESULTS: Of the 82 adult patients investigated, 50 patients (61%) had inflammatory diseases, 17 (21%) had solid malignancies, 12 (15%) had hematological malignancies, and 6 (7%) had received transplantations. All patients received immunosuppressive agents or antitumor chemotherapeutic drugs. Plasma (1→3) β-D-glucan levels were elevated in 80% of patients, and were significantly reduced after treatment in both survivors and non-survivors. However, β-D-glucan increased in 18% of survivors and was normal in only 33% after treatment. Concomitant invasive pulmonary aspergillosis was detected in 5 patients. Fifty-six respiratory samples were stored for genotyping. A dihydropteroate synthase mutation associated with trimethoprim-sulfamethoxazole resistance was found in only 1 of the 53 patients. The most prevalent genotype of mitochondrial large-subunit rRNA was genotype 1, followed by genotype 4. The most prevalent genotype of internal transcribed spacers of the nuclear rRNA operon was Eb, followed by Eg and Bi. Thirty-day mortality was 24%, in which logistic regression analysis revealed association with serum albumin and mechanical ventilation, but no association with genotypes. CONCLUSIONS: In non-HIV PCP, poorer general and respiratory conditions at diagnosis were independent predictors of mortality. β-D-glucan may not be useful for monitoring the response to treatment, and genotypes were not associated with mortality. BioMed Central 2011-03-25 /pmc/articles/PMC3073915/ /pubmed/21439061 http://dx.doi.org/10.1186/1471-2334-11-76 Text en Copyright ©2011 Matsumura et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Matsumura, Yasufumi Shindo, Yuichiro Iinuma, Yoshitsugu Yamamoto, Masaki Shirano, Michinori Matsushima, Aki Nagao, Miki Ito, Yutaka Takakura, Shunji Hasegawa, Yoshinori Ichiyama, Satoshi Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes |
title | Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes |
title_full | Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes |
title_fullStr | Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes |
title_full_unstemmed | Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes |
title_short | Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes |
title_sort | clinical characteristics of pneumocystis pneumonia in non-hiv patients and prognostic factors including microbiological genotypes |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073915/ https://www.ncbi.nlm.nih.gov/pubmed/21439061 http://dx.doi.org/10.1186/1471-2334-11-76 |
work_keys_str_mv | AT matsumurayasufumi clinicalcharacteristicsofpneumocystispneumoniainnonhivpatientsandprognosticfactorsincludingmicrobiologicalgenotypes AT shindoyuichiro clinicalcharacteristicsofpneumocystispneumoniainnonhivpatientsandprognosticfactorsincludingmicrobiologicalgenotypes AT iinumayoshitsugu clinicalcharacteristicsofpneumocystispneumoniainnonhivpatientsandprognosticfactorsincludingmicrobiologicalgenotypes AT yamamotomasaki clinicalcharacteristicsofpneumocystispneumoniainnonhivpatientsandprognosticfactorsincludingmicrobiologicalgenotypes AT shiranomichinori clinicalcharacteristicsofpneumocystispneumoniainnonhivpatientsandprognosticfactorsincludingmicrobiologicalgenotypes AT matsushimaaki clinicalcharacteristicsofpneumocystispneumoniainnonhivpatientsandprognosticfactorsincludingmicrobiologicalgenotypes AT nagaomiki clinicalcharacteristicsofpneumocystispneumoniainnonhivpatientsandprognosticfactorsincludingmicrobiologicalgenotypes AT itoyutaka clinicalcharacteristicsofpneumocystispneumoniainnonhivpatientsandprognosticfactorsincludingmicrobiologicalgenotypes AT takakurashunji clinicalcharacteristicsofpneumocystispneumoniainnonhivpatientsandprognosticfactorsincludingmicrobiologicalgenotypes AT hasegawayoshinori clinicalcharacteristicsofpneumocystispneumoniainnonhivpatientsandprognosticfactorsincludingmicrobiologicalgenotypes AT ichiyamasatoshi clinicalcharacteristicsofpneumocystispneumoniainnonhivpatientsandprognosticfactorsincludingmicrobiologicalgenotypes |